Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.


Figure 1


Figure 1— Change in SCVp and SCVi after 6 months of C-peptide therapy (n = 49, {blacksquare}) and placebo administration (n = 21, {square}) in the least affected half of the patients, i.e., those with SCVp >–2.5 SD at baseline. SCVi represents the fastest population of the axons in the nerve, whereas SCVp provides an estimate of the average conduction velocity. P values below the columns refers to within-group changes.





Right arrow Return to article

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum